Shopping Cart

Your shopping cart is currently empty

N-glycolyl-Ganglioside GM3 Mixture (ammonium salt)

Name: N-glycolyl-Ganglioside GM3 Mixture (ammonium salt)
Brand: TargetMol
SKU: T36413
Rating: 4.5 (1 reviews)

Copy Product Info

😃Good

Catalog No. T36413Cas No. 69345-49-9

Alias N-glycolyl-Ganglioside GM3 Mixture (ammonium salt)

N-glycolyl-Ganglioside GM3(NeuGc-GM3) is a form of ganglioside GM3 that contains an N-glycolylated sialic acid (NeuGc).

N-glycolyl-Ganglioside GM3 Mixture (ammonium salt)

Copy Product Info

😃Good

Catalog No. T36413Alias N-glycolyl-Ganglioside GM3 Mixture (ammonium salt)Cas No. 69345-49-9

N-glycolyl-Ganglioside GM3(NeuGc-GM3) is a form of ganglioside GM3 that contains an N-glycolylated sialic acid (NeuGc).

Pack Size	Price	USA Warehouse	Global Warehouse	Quantity
1 mg	Inquiry	Inquiry	Inquiry

Add to Quotation

In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]

All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Questions

Resource Download

Product Introduction

Bioactivity

Description	N-glycolyl-Ganglioside GM3(NeuGc-GM3) is a form of ganglioside GM3 that contains an N-glycolylated sialic acid (NeuGc).
In vitro	It is not biosynthesized in humans under baseline conditions due to a mutation in CMP-Neu5Ac hydroxylase (CMAH), which converts N-acetyl sialic acid to N-glycolyl sialic acid, but NeuGc can be taken up by human cellsviathe diet and incorporated into glycolipids, such as ganglioside GM3.1,2NeuGc-GM3 impairs differentiation and maturation of dendritic cellsin vitroand reduces CD4 expression in non-activated T cells.1,3It increases the number of lung tumor nodules formed in a murine Lewis lung carcinoma model.4It is found in a variety of human cancers, including breast and lung cancers, as well as pediatric cancers.1Levels of NeuGc-GM3 are negatively correlated with the number of mature dendritic cells in patient-derived non-small cell lung cancer (NSCLC) tumor tissue.5Anti-NeuGc-GM3 antibodies, able to destroy tumor cells in vitro, have been found in individuals without cancer but not in patients with NSCLC.1,6N-glycolyl-Ganglioside GM3mixture contains ganglioside GM3molecular species with primarily C22:0, C23:0, and C24:0 fatty acyl chain lengths.
Synonyms	N-glycolyl-Ganglioside GM3 Mixture (ammonium salt)

Chemical Properties

Molecular Weight	1284.7
Formula	C₆₄H₁₁₇N₂O₂₂NH₄
Cas No.	69345-49-9
Smiles	O[C@H]1[C@H](O[C@@H]([C@@H]([C@H]2O[C@]3(C([O-])=O)C[C@@H]([C@H]([C@]([C@@H]([C@H](O)CO)O)(O3)[H])NC(CO)=O)O)O)O[C@@H]([C@@H]2O)CO)[C@@H](CO)O[C@@H](OC[C@@H]([C@H](O)/C=C/CCCCCCCCCCCCC)NC([R])=O)[C@@H]1O.[NH4+]
Relative Density.	no data available

Storage & Solubility Information

Storage

Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Calculator

Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:

For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments

and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent

10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH₂O , the resulting working solution concentration would be 2 mg/mL.

Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSO TargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSO TargetMol | reagent stock solution to 400 μL PEG300 and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH₂O TargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.

All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

N-glycolyl-Ganglioside GM-3 Mixture (ammonium salt)NglycolylGanglioside GM3 Mixture (ammonium salt)N-glycolyl-Ganglioside GM3 MixtureN glycolyl Ganglioside GM3 Mixture (ammonium salt)

Related Tags: buy N-glycolyl-Ganglioside GM3 Mixture (ammonium salt) | purchase N-glycolyl-Ganglioside GM3 Mixture (ammonium salt) | N-glycolyl-Ganglioside GM3 Mixture (ammonium salt) cost | order N-glycolyl-Ganglioside GM3 Mixture (ammonium salt) | N-glycolyl-Ganglioside GM3 Mixture (ammonium salt) chemical structure | N-glycolyl-Ganglioside GM3 Mixture (ammonium salt) in vitro | N-glycolyl-Ganglioside GM3 Mixture (ammonium salt) formula | N-glycolyl-Ganglioside GM3 Mixture (ammonium salt) molecular weight